ISTODAX*
Manufacturer Details
GLOUCESTER PHARMACEUTICALS INC.
Compositions:
Romidepsin -mg,
Strength
|
Rate
|
Packing Style
|
mg
|
0.00
|
unit
|
List of Related Indications:
- Cutaneous T cell lymphoma ( CTCL )
List Of Drugs:
Indication Type Description:
Indication:
Proprietary Name- Istodax
Established Name - Romidepsin for Infusion- histone decacetylase (HAC)
inhibitor
Applicant- Gloucester Pharmaceuticals Inc.
Indication-
Cutaneous T-Cell Lymphoma (CTCL) who have received one prior
systemic therapy
Dosage-
14mg/m2 administered by IV infusion over 4hr on Day 1,8,15,on a 28 day cycle
Approved by FDA on 5-11-2010 (Ref- FDA approved List- 2010)
Dosages/ Overdosage Etc:
Indication-
Cutaneous T-Cell Lymphoma (CTCL) who have received one prior
systemic therapy
Dosage-
14mg/m2 administered by IV infusion over 4hr on Day 1,8,15,on a 28 day cycle